We are live on ! Find out more
TLSI icon

TriSalus Life Sciences
TLSI

19 hedge funds and large institutions have $5.85M invested in TriSalus Life Sciences in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,000% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 1

736% more capital invested

Capital invested by funds: $699K → $5.85M (+$5.15M)

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

111% more funds holding

Funds holding: 9 → 19 (+10)

2.1% more ownership

Funds ownership: 0.52% → 2.62% (+2.1%)

Holders
19
Holders Change
+10
Holders Change %
+111.11%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
3
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$850K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$559K
3
HA
HC Advisors
Georgia
+$524K
4
HF
HRT Financial
New York
+$247K
5
LNWWM
Laird Norton Wetherby Wealth Management
California
+$180K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$41.8K
2
WAM
Wolverine Asset Management
Illinois
-$2.12K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.4M +$850K +165,136 New
Geode Capital Management
2
Geode Capital Management
Massachusetts
$1.06M +$559K +108,523 +630%
HA
3
HC Advisors
Georgia
$860K +$524K +101,736 New
CWM
4
Connecticut Wealth Management
Connecticut
$483K – – –
HF
5
HRT Financial
New York
$405K +$247K +48,011 New
AC
6
Anson Capital
Georgia
$296K – – –
LNWWM
7
Laird Norton Wetherby Wealth Management
California
$295K +$180K +34,950 New
TWP
8
Tyche Wealth Partners
Texas
$225K +$137K +26,664 New
Morgan Stanley
9
Morgan Stanley
New York
$211K +$123K +23,841 +2,097%
Northern Trust
10
Northern Trust
Illinois
$154K +$93.6K +18,190 New
UBS Group
11
UBS Group
Switzerland
$142K -$41.8K -8,117 -33%
Creative Planning
12
Creative Planning
Kansas
$137K +$83.5K +16,216 New
Cambridge Investment Research Advisors
13
Cambridge Investment Research Advisors
Iowa
$131K +$80.1K +15,554 New
TRCT
14
Tower Research Capital (TRC)
New York
$16.7K +$10.2K +1,973 New
Wells Fargo
15
Wells Fargo
California
$11.1K +$6.77K +1,316 +131,600%
BlackRock
16
BlackRock
New York
$10.7K +$6.54K +1,270 New
HRC
17
Hoertkorn Richard Charles
$5.64K +$3.44K +668 New
GWSG
18
GPS Wealth Strategies Group
Colorado
$5.55K – – –
DM
19
Deerfield Management
New York
$8 – – –
WAM
20
Wolverine Asset Management
Illinois
– -$2.12K -415 Closed

TLSI Hedge Fund Activity: Q4 2023 in Review

19 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q4 2023, worth a combined $5.85M — up 736% from $699K a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new TLSI positions and 1 closed out — a net gain of 10 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $850K. The largest seller was UBS Group, cutting an estimated $41.8K.

  • 19 institutional investors held TriSalus Life Sciences (TLSI) as of Q4 2023, up from 9 in Q3 2023.
  • Funds reported $5.85M of TriSalus Life Sciences stock for Q4 2023, up 736% quarter-over-quarter.
  • 11 funds opened new TriSalus Life Sciences positions in Q4 2023 and 1 closed out, a net change of +10 holders.
  • The largest TriSalus Life Sciences buyer in Q4 2023 was Vanguard Group, an estimated $850K added.
  • The largest TriSalus Life Sciences seller in Q4 2023 was UBS Group, an estimated $41.8K sold.

Based on aggregated 13F filings for Q4 2023.